Ionis Pharmaceuticals Inc Metagenomi Collaboration Webcast Transcript
Good morning, and welcome to Ionis' Conference Call to discuss its collaboration with Metagenomi. (Operator Instructions) As a reminder, this call is being recorded.
At this time, I would like to turn the call over to Jennifer Capuzelo, Investor Relations, to lead off the call. Please begin.
Thank you, Joe. Hello, and thank you for joining us this morning for our discussion about our collaboration with Metagenomi.
Before we begin, I encourage everyone to review the press release Ionis issued this morning, which outlines the details of this agreement. We have also posted slides on our website that accompany today's call.
Joining me on today's call are Brett Monia, Chief Executive Officer; Frank Bennett, Chief Scientific Officer; and Eric Swayze, Executive Vice President of Research. And joining us for the Q&A portion of the call are Joseph Baroldi, Chief Business Officer; and Beth Hougen, Chief Financial Officer.
During this call, we will be making forward-looking statements that are based on our current
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |